Severe aplastic anemia (sAA) is a bone marrow failure disorder which is mostly a consequence of immunologically mediated stem cell destruction. Allogeneic bone marrow transplantation (BMT) from a ...

For patients with acquired severe aplastic anemia without a matched sibling donor and not responding to immunosuppressive treatment, bone marrow transplantation from a suitable alternative donor ...

Aplastic anemia develops when the bone marrow is damaged, and it can no longer synthesize enough stem cells. Stem cells are cells that give rise to other blood cells.

Aplastic anemia can be managed by following a treatment plan and monitoring symptoms. To prevent excessive bleeding, one must avoid high-contact activities and sports like football, hockey, or ...

Aplastic anemia is a rare disease resulting from diverse immune-mediated, direct, and acquired pathologic processes. Diagnostic and therapeutic advances have improved survival.

Sixty-five-year-old Lalaram Yadav from Jaipur had nearly given up hope. With his haemoglobin levels dangerously low-hovering ...

Eltrombopag increased response rates when added to standard immunosuppressive therapy among patients with transplant-ineligible severe aplastic anemia, according to phase 3 study results published ...

Aplastic anemia is a challenging disorder for the patient as well as the hematologist. Due to its rarity and complexity, there is a lack of public awareness about aplastic anemia.

Aplastic anaemia can strike anyone, regardless of age or gender, making awareness efforts vital in reaching a broad audience. Common symptoms include fatigue, paleness, frequent infections, and ...

Tamil Nadu Aplastic Anaemia Registry (STAR) launched at RGGGH to improve early diagnosis and access to treatment options.

The rise in awareness of Aplastic Anemia has led to the increased Research & Development activities in the pharmaceutical sector and the development of pipeline products such as PF-06462700 ...

Farmington, May 08, 2023 (GLOBE NEWSWIRE) -- The Global Acquired Aplastic Anemia Market size was valued at USD 7.27 billion in 2022 and is projected to reach USD 10.25 billion by 2030, growing at ...